Back to Clinical Nutrition
Clinical Nutritionv2005Evidence-Based

Fat Free Mass (FFM)

Calculates the predictive value of fat-free mass from body weight and body mass index (BMI). Useful for weight-based medication dosing, especially in anesthesia, and helps calculate body composition.

Clinical Input Parameters

kg
Range: 10 — 300 kg
kg/m²
Range: 10 — 80 kg/m²
Clinical Assessment
Awaiting Parameters
fat free mass
—kg
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Fat Free Mass (FFM) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within clinical nutrition.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Male: FFM = (9.27 × 10³ × Body Weight) / (6.68 × 10³ + 216 × BMI), Female: FFM = (9.27 × 10³ × Body Weight) / (8.78 × 10³ + 244 × BMI)

Clinical Pearls & Practice Notes

  • Useful for weight-based medication dosing, especially in anesthesia
  • Attempts to exclude lipids in cellular membranes
  • Includes bone mass, organs, muscle, and water content
  • Predictive equation, not a direct measurement
  • Should be used alongside clinical judgment
  • Particularly valuable in patients with obesity for medication dosing

Evidence & Literature Citations

  1. Janmahasatian S, Duffull SB, Ash S, Ward LC, Byrnes NM, Green B. Quantification of lean bodyweight. Clin Pharmacokinet. 2005;44(10):1051-65. doi: 10.2165/00003088-200544100-00004.
  2. La Colla L, Albertin A, La Colla G, Mangano A. Predictive value of the Janmahasatian formula for lean body weight in the dosing of sugammadex in morbidly obese patients. Anaesthesia. 2010 Apr;65(4):445-6. doi: 10.1111/j.1365-2044.2010.06284.x.
  3. Green B, Duffull SB. What is the best size descriptor to use for pharmacokinetic studies in the obese? Br J Clin Pharmacol. 2004 Aug;58(2):119-33. doi: 10.1111/j.1365-2125.2004.02157.x.

Score Interpretation Ranges

Calculated0 – 1000 pts

Fat-free mass estimation

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.